Protara Therapeutics

(NASDAQ) TARA

Current Price$3.99

Market Cap$223.69M

Since IPO (2020)-87%

5 Year-62%

1 Year+34%

1 Month-8%

Protara Therapeutics Financials at a Glance

Market Cap

$223.69M

Revenue (TTM)

$0.00

Net Income (TTM)

-$63.31M

EPS (TTM)

-$1.35

P/E Ratio

-2.94

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$3.99

Volume

20,351

Open

$4.14

Price

$3.99

Volume

20,351

Open

$4.14

Previous Close

$3.99

Daily Range

$3.99 - $4.18

52-Week Range

$2.77 - $7.82

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$3.99

Volume

20,351

Open

$4.14

Previous Close

$3.99

Daily Range

$3.99 - $4.18

52-Week Range

$2.77 - $7.82

Estimated Earnings Date

Aug 11, 2026

TARA News

Protara Beats Q2 Loss Estimates

Motley Fool Markets TeamAug 11, 2025

TARA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Protara Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jesse Shefferman, MBA

Website

www.protaratx.com

Headquarters

New York City, NY 10010, US

TARA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-37%

Return on Capital

-38%

Return on Assets

-33%

Earnings Yield

-34.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$223.69M

Shares Outstanding

56.20M

Volume

20.35K

Avg. Volume

736.62K

Financials (TTM)

Gross Profit

-$362.00K

Operating Income

-$64.55M

EBITDA

-$57.08M

Operating Cash Flow

-$56.37M

Capital Expenditure

-$94.00K

Free Cash Flow

-$56.46M

Cash & ST Invst.

$155.55M

Total Debt

$3.36M

Protara Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$90.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$223.69M

N/A

Market Cap/Employee

$7.99M

N/A

Employees

N/A

Net Income

-$17.78M

-49.3%

EBITDA

-$17.69M

-49.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$135.79M

+9.2%

Total Debt

$3.06M

-27.7%

Accounts Receivable

$1.52M

+312.2%

Inventory

$0.00

N/A

Long Term Debt

$1.79M

-41.3%

Short Term Debt

$1.26M

+8.0%

Return on Assets

-32.99%

N/A

Return on Invested Capital

-38.28%

N/A

Free Cash Flow

-$21.34M

-44.6%

Operating Cash Flow

-$21.34M

-45.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.57+3.63%

OBIOOrchestra BioMed Holdings, Inc.

OBIOOrchestra BioMed Holdings, Inc.$3.99+3.10%

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$4.32-0.69%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$2.34+15.27%

MDWDMediWound Ltd.

MDWDMediWound Ltd.$14.24+0.28%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$0.97+4.16%

NTHINeonc Technologies Holdings, Inc.

NTHINeonc Technologies Holdings, Inc.$5.27+9.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

PFEPfizer

PFEPfizer$25.21-0.03%

TAT&T

TAT&T$22.01-0.02%

QSQuantumScape

QSQuantumScape$8.04+0.17%

SOFISoFi Technologies

SOFISoFi Technologies$17.91+0.03%

FLEXFlex

FLEXFlex$147.61+0.03%

Questions About TARA

What is the current price of Protara Therapeutics?

Protara Therapeutics is trading at $3.99 per share.

What is the 52-week range for Protara Therapeutics?

Over the past 52 weeks, Protara Therapeutics has traded between $2.77 and $7.82.

How much debt does Protara Therapeutics have?

As of the most recent reporting period, Protara Therapeutics reported total debt of $3.06M.

How much cash does Protara Therapeutics have on hand?

Protara Therapeutics reported $14.74M in cash and cash equivalents in its most recent financial results.

What is Protara Therapeutics’s dividend yield?

Protara Therapeutics does not currently have a dividend yield.

Protara Therapeutics

Protara Therapeutics Financials at a Glance

TARA News

Protara Beats Q2 Loss Estimates

TARA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Protara Therapeutics

TARA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Protara Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TARA

What is the current price of Protara Therapeutics?

What is the 52-week range for Protara Therapeutics?

How much debt does Protara Therapeutics have?

How much cash does Protara Therapeutics have on hand?

What is Protara Therapeutics’s dividend yield?

Premium Investing Services